Abstract
BackgroundCharacterization of the tumor microenvironment is becoming a clinical reality for discovering evidence of novel treatments’ efficacy. Multiplex immunofluorescence (mIF) assays have emerged as potent tools for immune-profiling analysis to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
